APT-weighted MRI: Techniques, current neuro applications, and challenging issues
- PMID: 30663162
- PMCID: PMC6625919
- DOI: 10.1002/jmri.26645
APT-weighted MRI: Techniques, current neuro applications, and challenging issues
Abstract
Amide proton transfer-weighted (APTw) imaging is a molecular MRI technique that generates image contrast based predominantly on the amide protons in mobile cellular proteins and peptides that are endogenous in tissue. This technique, the most studied type of chemical exchange saturation transfer imaging, has been used successfully for imaging of protein content and pH, the latter being possible due to the strong dependence of the amide proton exchange rate on pH. In this article we briefly review the basic principles and recent technical advances of APTw imaging, which is showing promise clinically, especially for characterizing brain tumors and distinguishing recurrent tumor from treatment effects. Early applications of this approach to stroke, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and traumatic brain injury are also illustrated. Finally, we outline the technical challenges for clinical APT-based imaging and discuss several controversies regarding the origin of APTw imaging signals in vivo. Level of Evidence: 3 Technical Efficacy Stage: 3 J. Magn. Reson. Imaging 2019;50:347-364.
Keywords: APT-weighted imaging; CEST imaging; brain tumor; molecular imaging; stroke.
© 2019 International Society for Magnetic Resonance in Medicine.
Conflict of interest statement
Disclosure of Potential Conflicts of Interest
J.Z. and P.C.M.v.Z. are co-inventors on a patent for the APT MRI technology. This patent is owned and managed by Johns Hopkins University. P.C.M.v.Z. is a paid lecturer for Philips Medical Systems. This arrangement has been approved by The Johns Hopkins University in accordance with its Conflict of Interest policies.
Figures









Similar articles
-
Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.J Magn Reson Imaging. 2016 Jul;44(1):41-50. doi: 10.1002/jmri.25108. Epub 2015 Dec 10. J Magn Reson Imaging. 2016. PMID: 26663561 Free PMC article.
-
Generalization of quasi-steady-state reconstruction to CEST MRI with two-tiered RF saturation and gradient-echo readout-Synergistic nuclear Overhauser enhancement contribution to brain tumor amide proton transfer-weighted MRI.Magn Reson Med. 2023 May;89(5):2014-2023. doi: 10.1002/mrm.29570. Epub 2022 Dec 29. Magn Reson Med. 2023. PMID: 36579767
-
Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions.Jpn J Radiol. 2019 Feb;37(2):109-116. doi: 10.1007/s11604-018-0787-3. Epub 2018 Oct 19. Jpn J Radiol. 2019. PMID: 30341472 Review.
-
Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.NMR Biomed. 2014 Feb;27(2):163-74. doi: 10.1002/nbm.3048. Epub 2013 Nov 28. NMR Biomed. 2014. PMID: 24288260 Free PMC article. Clinical Trial.
-
Amide Proton Transfer-Weighted MR Imaging of Pediatric Central Nervous System Diseases.Magn Reson Imaging Clin N Am. 2021 Nov;29(4):631-641. doi: 10.1016/j.mric.2021.06.012. Magn Reson Imaging Clin N Am. 2021. PMID: 34717850 Review.
Cited by
-
The Role of Amide Proton Transfer (APT)-Weighted Imaging in Glioma: Assessment of Tumor Grading, Molecular Profile and Survival in Different Tumor Components.Cancers (Basel). 2024 Aug 29;16(17):3014. doi: 10.3390/cancers16173014. Cancers (Basel). 2024. PMID: 39272871 Free PMC article.
-
Amide Proton Transfer Weighted and Intravoxel Incoherent Motion Imaging in Evaluation of Prognostic Factors for Rectal Adenocarcinoma.Front Oncol. 2022 Jan 3;11:783544. doi: 10.3389/fonc.2021.783544. eCollection 2021. Front Oncol. 2022. PMID: 35047400 Free PMC article.
-
CEST and nuclear Overhauser enhancement imaging with deep learning-extrapolated semisolid magnetization transfer reference: Scan-rescan reproducibility and reliability studies.Magn Reson Med. 2024 Mar;91(3):1002-1015. doi: 10.1002/mrm.29937. Epub 2023 Nov 27. Magn Reson Med. 2024. PMID: 38009996 Free PMC article.
-
Sub-region based histogram analysis of amide proton transfer-weighted MRI for predicting tumor budding grade in rectal adenocarcinoma: a prospective study.Eur Radiol. 2025 Mar;35(3):1382-1393. doi: 10.1007/s00330-024-11172-x. Epub 2024 Nov 5. Eur Radiol. 2025. PMID: 39500798
-
Amide proton transfer and apparent diffusion coefficient analysis reveal susceptibility of brain regions to neonatal hypoxic-ischemic encephalopathy.Heliyon. 2024 Sep 19;10(18):e38062. doi: 10.1016/j.heliyon.2024.e38062. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39347396 Free PMC article.
References
-
- Forsen S, Hoffman RA. Study of moderately rapid chemical exchange reactions by means of nuclear magnetic double resonance. J Chem Phys 1963;39:2892–901.
-
- Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000;143:79–87. - PubMed
-
- Zhou J, van Zijl PC. Chemical exchange saturation transfer imaging and spectroscopy. Progr NMR Spectr 2006;48:109–36.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical